Compare HLN & IBKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HLN | IBKR |
|---|---|---|
| Founded | 2022 | 1977 |
| Country | United Kingdom | United States |
| Employees | N/A | 2998 |
| Industry | Package Goods/Cosmetics | Investment Bankers/Brokers/Service |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.5B | 38.7B |
| IPO Year | 2021 | 2006 |
| Metric | HLN | IBKR |
|---|---|---|
| Price | $9.05 | $77.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 17 |
| Target Price | $10.40 | ★ $104.04 |
| AVG Volume (30 Days) | ★ 21.8M | 5.1M |
| Earning Date | 07-30-2026 | 10-15-2026 |
| Dividend Yield | ★ 2.19% | 0.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.98 |
| Revenue | N/A | ★ $2,580,000,000.00 |
| Revenue This Year | $2.35 | $19.72 |
| Revenue Next Year | $3.29 | $19.70 |
| P/E Ratio | $49.05 | ★ $39.18 |
| Revenue Growth | N/A | ★ 9.04 |
| 52 Week Low | $8.38 | $58.95 |
| 52 Week High | $11.28 | $98.75 |
| Indicator | HLN | IBKR |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 42.44 |
| Support Level | $8.67 | $74.62 |
| Resistance Level | $9.29 | $79.18 |
| Average True Range (ATR) | 0.19 | 3.00 |
| MACD | -0.07 | -0.13 |
| Stochastic Oscillator | 33.00 | 42.16 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Interactive Brokers is a large, automated retail and institutional brokerage that boasted nearly $780 billion in customer equity at the end of 2025. The company cut its teeth as a market maker, introducing US financial markets to automated and algorithmic training before expanding into brokerage services in 1993. The firm has a wide-ranging client base, with its best-in-class order execution and extremely low margin lending rates catering to a sophisticated audience of hedge funds, proprietary traders, and introducing brokers that account for about 45% of the firm's commissions. With operations spanning more than 170 electronic exchanges, 40 countries, and 29 currencies, Interactive Brokers caters to a global clientele, with more than 80% of client accounts sitting outside the US.